NCT00289900
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
See it on ClinicalTrials.gov ↗2,340 people
55.9%
44.1%
1,309 womenmiddle line = equal numbers1,031 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 2010-08-06
- Health conditions
- Mixed Hyperlipidemia
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 54.7 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating women, or women intending to become pregnant”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating women, or women intending to become pregnant”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Active or chronic liver disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Any of the following within the past 3 months: heart attack, stoke, heart bypass surgery, unstable angina, angioplasty”
- No diabetes
Women with diabetes were turned away.
“Diabetes mellitus that is poorly controlled, newly diagnosed, or taking new or recently adjusted antidiabetic therapy (with the exception of ± 10 units of insulin)”
Study titles and rules are shown in their original English.